Varaico: Literature-Extracted Genetic Variants

Gene:MYOC
Variant:p.P481L
Back to variants list

MYOC

NM_000261.2:p.P481L

Associated Papers

Protein misfolding and mitochondrial dysfunction in glaucoma.

Venkatesan A et al.

Frontiers in Cell and Developmental Biology, 2025

Somatic Mutations within Myocilin due to Aging May Be a Potential Risk Factor for Glaucoma.

Sazhnyev Y et al.

Genes, 2024

38397193 (PubMed )
Supplement: genes-15-00203-s001.zip › genes-2821445-supplementary.xlsx › Sheet1

Myocilin misfolding and glaucoma: A 20-year update.

Saccuzzo EG et al.

Progress in Retinal and Eye Research, 2023

Quantitative differentiation of benign and misfolded glaucoma-causing myocilin variants on the basis of protein thermal stability.

Scelsi HF et al.

Disease Models & Mechanisms, 2023

Structure‒function‒pathogenicity analysis of C-terminal myocilin missense variants based on experiments and 3D models.

Zhou B et al.

Frontiers in Genetics, 2022

36267417 (PubMed )
Supplement: Table3.xlsx › Sheet1

Age at Glaucoma Diagnosis in Germline Myocilin Mutation Patients: Associations with Polymorphisms in Protein Stabilities.

Tanji T et al.

Genes, 2021

Common and rare myocilin variants: Predicting glaucoma pathogenicity based on genetics, clinical, and laboratory misfolding data.

Scelsi HF et al.

Human Mutation, 2021

Molecular Insights into Myocilin and Its Glaucoma-Causing Misfolded Olfactomedin Domain Variants.

Lieberman RL et al.

Accounts of Chemical Research, 2021

Physiological function of myocilin and its role in the pathogenesis of glaucoma in the trabecular meshwork (Review).

Wang H et al.

International Journal of Molecular Medicine, 2019

Structural basis for misfolding in myocilin-associated glaucoma.

Donegan RK et al.

Human Molecular Genetics, 2015

The glaucoma-associated olfactomedin domain of myocilin is a novel calcium binding protein.

Donegan RK et al.

The Journal of Biological Chemistry, 2012

The stability of myocilin olfactomedin domain variants provides new insight into glaucoma as a protein misfolding disorder.

Burns JN et al.

Biochemistry, 2011

New mutation in the MYOC gene and its association with primary open-angle glaucoma in a Chinese family.

Qu X et al.

Molecular Biology Reports, 2010

Two novel myocilin mutations in a Chinese family with primary open-angle glaucoma.

Xie X et al.

Molecular Vision, 2008

Functional analysis of the glaucoma-causing TIGR/myocilin protein: integrity of amino-terminal coiled-coil regions and olfactomedin homology domain is essential for extracellular adhesion and secretion.

Gobeil S et al.

Experimental Eye Research, 2006

Molecular analysis of the myocilin gene in Chinese subjects with chronic primary-angle closure glaucoma.

Aung T et al.

Investigative Ophthalmology & Visual Science, 2005

Genetic dissection of myocilin glaucoma.

Gong G et al.

Human Molecular Genetics, 2004

The dawn of genetic testing for glaucoma.

Cohen CS et al.

Current Opinion in Ophthalmology, 2004

Founder TIGR/myocilin mutations for glaucoma in the Québec population.

Faucher M et al.

Human Molecular Genetics, 2002

A multidomain TIGR/olfactomedin protein family with conserved structural similarity in the N-terminal region and conserved motifs in the C-terminal region.

Green ML et al.

Molecular & Cellular Proteomics : Mcp, 2002

Analysis of myocilin gene mutations in Japanese patients with normal tension glaucoma and primary open-angle glaucoma.

Mabuchi F et al.

Clinical Genetics, 2001

Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension.

Fingert JH et al.

Investigative Ophthalmology & Visual Science, 2001

Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.

Fingert JH et al.

Human Molecular Genetics, 1999

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."